Preimplantation Genetic Testing Market is Set to Reach USD 6.5 Billion, with a Healthy 11.7% CAGR Till Forecasts 2035

WiseGuy Reports, Oct. 2025 (Press Release) – The Preimplantation Genetic Testing Market Global Outlook:

Global Preimplantation Genetic Testing Market Growth Analysis and Trends Report Test Type (Preimplantation Genetic Diagnosis, Preimplantation Genetic Screening, Comprehensive Chromosomal Screening), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, Microarray), By Application (Infertility Treatment, Genetic Disease Prevention, Sex Selection), By End Use (Fertility Clinics, Research Laboratories, Hospitals) and By Regions - Global Industry Forecast 2025 to 2035

Preimplantation Genetic Testing Market Overview

The Preimplantation Genetic Testing Market is rapidly expanding as fertility clinics, genetic laboratories, and biotechnology firms leverage genomic innovations to enhance reproductive health outcomes. Valued at USD 1.91 billion in 2024, the market is expected to reach USD 6.5 billion by 2035, registering a robust CAGR of 11.7% between 2025 and 2035. Preimplantation genetic testing (PGT) enables the identification of genetic abnormalities in embryos before implantation during in vitro fertilization (IVF) procedures, significantly improving pregnancy success rates and reducing the risk of hereditary disorders. With technological advancements in genomics and increasing awareness about genetic health, the market continues to gain momentum globally.

Request To Free Sample of This Strategic Report –

https://www.wiseguyreports.com/sample-request?id=736093

Market Dynamics

The growth of the Preimplantation Genetic Testing Market is driven by multiple factors. Rising infertility rates worldwide, influenced by lifestyle changes, delayed pregnancies, and medical conditions, are increasing demand for assisted reproductive technologies (ART). Simultaneously, technological innovations such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) are enabling precise and efficient genetic screening of embryos. Increased awareness and education regarding hereditary diseases are pushing patients and clinicians toward preventive genetic testing solutions. Moreover, regulatory bodies across regions are establishing supportive frameworks and guidelines to ensure the ethical and safe implementation of PGT, encouraging broader adoption among fertility centers and genetic clinics.

Key Growth Drivers

Rising infertility and the growing acceptance of IVF are major contributors to the market expansion. The World Health Organization estimates that nearly one in six adults experience infertility, leading to increased utilization of ART services where PGT plays a critical role. In addition, the surge in personalized medicine initiatives is strengthening the integration of genetic testing into fertility treatments, offering tailored solutions for couples with specific genetic risks. Furthermore, favorable reimbursement policies and the inclusion of genetic counseling in healthcare plans are promoting access to PGT services, particularly in developed markets.

🛒 Buy Now Premium Research Report –

https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=736093

Market Opportunities

The Preimplantation Genetic Testing Market presents substantial opportunities for B2B stakeholders across biotechnology, diagnostics, and reproductive medicine. Rising demand for genetic testing services and infertility treatment centers is creating new growth avenues for technology providers and diagnostic laboratories. Continuous technological advancements in genomics—including automation, microarrays, and artificial intelligence-driven data interpretation—are enhancing testing accuracy and turnaround time. Expanding healthcare investments in developing countries, coupled with growing awareness about hereditary disease prevention, are further strengthening the market potential. Moreover, collaborations between fertility clinics and genetic testing companies are fostering integrated service delivery models, enabling comprehensive patient care.

Market Segmentation

The market is segmented by Test Type, Technology, Application, End Use, and Region.

• Test Type: Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS), and Preimplantation Genetic Testing for Aneuploidy (PGT-A). PGT-A dominates due to its critical role in identifying chromosomal abnormalities that affect embryo viability.
• Technology: Key technologies include Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Comparative Genomic Hybridization (CGH), and Fluorescence In Situ Hybridization (FISH). NGS is projected to lead the segment due to its higher sensitivity and accuracy.
• Application: PGT is extensively used in identifying monogenic diseases, structural chromosomal rearrangements, and aneuploidies.
• End Use: Major end users include fertility clinics, hospitals, and research laboratories, with fertility clinics accounting for the largest share due to the rising number of IVF procedures globally.

Regional Insights

The Preimplantation Genetic Testing Market demonstrates strong growth across all major regions — North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA).

• North America leads the market owing to a high number of IVF procedures, well-established fertility centers, and the presence of key genetic testing companies. The U.S. remains a major contributor with strong insurance coverage and advanced healthcare infrastructure.
• Europe follows closely, supported by favorable government initiatives, ethical guidelines for embryo testing, and a high adoption rate of ART technologies in countries such as the UK, Germany, and France.
• Asia-Pacific is anticipated to witness the fastest growth, driven by increasing healthcare spending, expanding fertility tourism in countries like India and Thailand, and growing awareness of genetic health.
• South America and MEA are emerging regions showing gradual adoption, supported by improving healthcare access and awareness programs focusing on infertility and genetic disorders.

Browse In-depth Market Research Report (Pages, Charts, Tables, Figures)

https://www.wiseguyreports.com/reports/preimplantation-genetic-testing-market

Competitive Landscape

The Preimplantation Genetic Testing Market is highly competitive, with several established and emerging players focusing on technological advancement, product expansion, and partnerships with fertility centers. Key companies include:

• Beckman Coulter
• Illumina
• CooperSurgical
• Thermo Fisher Scientific
• Roche
• Agilent Technologies
• Natera
• PerkinElmer
• Prelude Fertility
• Reproductive Health Specialists
• Genea Limited
• Fulgent Genetics
• Genetics and IVF Institute
• Laboratory Corporation of America Holdings
• Myriad Genetics
• Oxford Gene Technology

These companies are actively investing in R&D to improve testing platforms, develop cost-effective solutions, and strengthen their presence through mergers, acquisitions, and clinical collaborations.

Trends and Future Outlook

The future of the Preimplantation Genetic Testing Market lies in integrating advanced technologies with clinical workflows to optimize embryo selection and treatment outcomes. The adoption of AI-driven analytics is enhancing embryo viability assessment, while automation in laboratories is improving efficiency and reducing errors. Moreover, the combination of genetic testing with digital health platforms is enabling remote consultations and genetic counseling, expanding accessibility. As awareness grows and regulatory clarity improves, more fertility centers are expected to incorporate PGT as a standard component of IVF treatment.

Reasons To Buy The Preimplantation Genetic Testing Market Report:

➼ In-depth analysis of the Preimplantation Genetic Testing Market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Other Related Reports from Latest WiseGuy Reports:

Anti GFP Antibody Market

Hemorrhoid Cream Market

Idiopathic Intracranial Hypertension Treatment Market

Telehealth Systems Market

Polymyxin B Sulfate Market

Eye Vitamins Market

Protein Gel Market

Dengue Fever Treatment Market

Renal Cyst Treatment Market

Sacroiliitis Treatment Market

About US:

Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets